移动端

Anti-NMP-22抗体,核基质蛋白22抗体技术参数

2013年05月13日 15:25博研科研试剂网点击量:678

博研科研试剂网*的实验室采购专家,为您推荐:

                         

                         Anti-NMP-22抗体,核基质蛋白22抗体技术参数
Catalog Number : BYK- 2451R
Quantity size : 0.1ml (dilute with pH 7.4 0.01 M PBS or antibody diluent )
Background: Healthy individuals generally have very small amounts of NMP22 protein in the urine. However, the level of NMP22 protein is often elevated in the urine of patients with bladder cancer, even at early stages of the disease.1 The Alere NMP22 Test is an enzyme immunoassay for the quantitative determination of nuclear mitotic apparatus protein (NuMA) in stabilized voided urine. NuMA is an abundant component of the nuclear matrix proteins (NMP22). The Alere NMP22?BladderChek?Test is the only in-office test approved by the FDA as an aid in the diagnosis and monitoring of bladder cancer in conjunction with standard diagnostic procedures. Both assays are painless and non-invasive and detect elevated levels of NMP22 protein.
Specificity :
–Anti- NMP-22 is a Rabbit polyclonal antibody unconjugated
–specific for NMP-22 of hu, mo, rat
–use for western blotting,elisa,immunoprecipitation and immunohistochemistry
–Protein G affinity chromatography purification, purity :>95%
–Isotype: IgG
–mol wt: 69kDa

Anti-NMP-22抗体,核基质蛋白22抗体技术参数Application :
–Western blotting 1:100-500
–Immunohistochemistry 1:100-500
–ELISA 1:500-1000
–Optimal working dilutions must be determined by the end user.

Storage: Store at -20℃ for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20℃. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody, the antibody is stable for at least six weeks at 2-4 ℃

Anti-NMP-22抗体,核基质蛋白22抗体技术参数Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.

版权与免责声明: 凡本网注明“来源:智慧城市网”的所有作品,均为浙江兴旺宝明通网络有限公司-智慧城市网合法拥有版权或有权使用的作品,未经本网授权不得转载、摘编或利用其它方式使用上述作品。已经本网授权使用作品的,应在授权范围内使用,并注明“来源:智慧城市网www.afzhan.com”。违反上述声明者,本网将追究其相关法律责任。

本网转载并注明自其它来源(非智慧城市网www.afzhan.com)的作品,目的在于传递更多信息,并不代表本网赞同其观点或和对其真实性负责,不承担此类作品侵权行为的直接责任及连带责任。其他媒体、网站或个人从本网转载时,必须保留本网注明的作品第一来源,并自负版权等法律责任。

编辑精选

更多

本站精选

更多

视频直击

更多

专题推荐

更多

名企推荐

更多

浙公网安备 33010602000006号